Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Urine extracellular vesicles capture kidney transcriptome and hyperglycemia linked mRNA signatures for type 1 diabetic kidney disease

View ORCID ProfileOm Prakash Dwivedi, Karina Barreiro, Annemari Käräjämäki, View ORCID ProfileErkka Valo, View ORCID ProfileRashmi B Prasad, Harry Holthöfer, View ORCID ProfilePer-Henrik Groop, View ORCID ProfileTiinamaija Tuomi, View ORCID ProfileCarol Forsblom, View ORCID ProfileLeif Groop, View ORCID ProfileMaija Puhka
doi: https://doi.org/10.1101/2021.10.11.21264829
Om Prakash Dwivedi
1Institute for Molecular Medicine Finland FIMM, HiLIFE, University of Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Om Prakash Dwivedi
  • For correspondence: om.dwivedi@helsinki.fi maija.puhka@helsinki.fi
Karina Barreiro
1Institute for Molecular Medicine Finland FIMM, HiLIFE, University of Helsinki, Finland
2Institute for Molecular Medicine Finland FIMM, EV Core, University of Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annemari Käräjämäki
3Department of Primary Health Care, Vaasa Central Hospital, Hietalahdenkatu 2-4, 65130 Vaasa, Finland & Diabetes Center, Vaasa Health Care Center, Sepänkyläntie 14-16, 65100 Vaasa, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erkka Valo
4Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland
5Department of Nephrology, University of Helsinki and Helsinki University Hospital, Finland
6Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erkka Valo
Rashmi B Prasad
7Lund University Diabetes Centre, Department of Clinical Sciences Malmö, Lund University, Skåne University Hospital, Malmö, SE-20513, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rashmi B Prasad
Harry Holthöfer
1Institute for Molecular Medicine Finland FIMM, HiLIFE, University of Helsinki, Finland
8Department of Medicine, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Per-Henrik Groop
4Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland
5Department of Nephrology, University of Helsinki and Helsinki University Hospital, Finland
6Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Finland
9Department of Diabetes, Central Clinical School Monash University Melbourne VIC Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Per-Henrik Groop
Tiinamaija Tuomi
1Institute for Molecular Medicine Finland FIMM, HiLIFE, University of Helsinki, Finland
4Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland
7Lund University Diabetes Centre, Department of Clinical Sciences Malmö, Lund University, Skåne University Hospital, Malmö, SE-20513, Sweden
10Endocrinology, Abdominal Centre, Helsinki University Hospital, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tiinamaija Tuomi
Carol Forsblom
1Institute for Molecular Medicine Finland FIMM, HiLIFE, University of Helsinki, Finland
4Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland
5Department of Nephrology, University of Helsinki and Helsinki University Hospital, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carol Forsblom
Leif Groop
1Institute for Molecular Medicine Finland FIMM, HiLIFE, University of Helsinki, Finland
7Lund University Diabetes Centre, Department of Clinical Sciences Malmö, Lund University, Skåne University Hospital, Malmö, SE-20513, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Leif Groop
Maija Puhka
1Institute for Molecular Medicine Finland FIMM, HiLIFE, University of Helsinki, Finland
2Institute for Molecular Medicine Finland FIMM, EV Core, University of Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maija Puhka
  • For correspondence: om.dwivedi@helsinki.fi maija.puhka@helsinki.fi
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Diabetic kidney disease (DKD) is a severe complication of type 1 diabetes (T1D), which lacks non-invasive early biomarkers. Although less explored, mRNAs in urinary extracellular vesicles (uEV) could reflect changes in the kidney transcriptome during DKD development. We performed genome-wide mRNA sequencing of >100 uEV samples from two T1D cohorts with 24-hour and overnight urine collections. Our uEV pipeline allowed reproducible detection of >10,000 mRNAs bearing overall similarity to kidney transcriptome. uEV from T1D DKD groups showed significant upregulation of 13 genes, prevalently expressed by proximal tubular cells within the kidney. Strikingly, six genes involved in cellular stress responses including protection against oxidative stress (GPX3, NOX4, MSRB, MSRA, HRSP12 and CRYAB) correlated with hyperglycemia and long-term changes in kidney function independent of albuminuria status. The study identified genes associated with glycemic stress in T1D DKD and confirmed the utility of uEV in capturing pathological gene expression signatures from kidney.

Competing Interest Statement

L.G. has received research funding from Pfizer Inc, Regeneron Pharmaceuticals, Eli Lilly and Astra Zeneca. P-H.G. has received research grants from Eli Lilly and Roche; is an advisory board member for AbbVie, AstraZeneca, Boehringer Ingelheim, Cebix, Eli Lilly, Jansen, MSD, Novartis, NovoNordisk and Sanofi; and has received lecture fees from Boehringer Ingelheim, Eli Lilly, Elo Water, Genzyme, MSD, Novartis, Novo Nordisk and Sanofi. The funding sources were not involved in the design or conduct of the study.

Funding Statement

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115974 (BEAt-DKD). This Joint Undertaking receives support from the European Union Horizon 2020 research and innovation programme and EFPIA with JDRF. The Direva Study (A.K.) has been supported by the Vasa Hospital District, State Research Funding via the Turku University Hospital, Vasa Central Hospital, Jakobstadsnejdens Heart Foundation, the Medical Foundation of Vaasa and the Finnish Medical Foundation. This substudy has also been financially supported (LG, TT) by grants from Folkhälsan Research Foundation, the Sigrid Juselius Foundation, the Academy of Finland (grants no. 263401, 267882, 312063, 336822 to LG: 312072,336826 to TT: 317599 to OPD), University of Helsinki, Ollqvist Foundation, and the Health Care Center in Vasa. The FinnDiane study was supported by grants from Folkhälsan Research Foundation, Wilhelm and Else Stockmann Foundation, Liv och Hälsa Society, Helsinki University Central Hospital Research Funds (EVO), Novo Nordisk Foundation (NNFOC0013659), and Academy of Finland (299200 and 316664).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study protocol for this substudy of the FinnDiane and DIREVA studies was approved by the Ethics Committee of the Turku University Hospital. The study protocol of the FinnDiane Study has also been approved by the Ethical Committee of the Helsinki and Uusimaa Hospital District (FinnDiane 163/E5/04, 199/E5/05, 491/E5/2006, 238/13/03/00/15), and that of DIREVA, by the Ethical Committees of the Vaasa Central Hospital (6/2007) and Turku University Hospital (48/1801/2014, 116/1805/2016). All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 14, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Urine extracellular vesicles capture kidney transcriptome and hyperglycemia linked mRNA signatures for type 1 diabetic kidney disease
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Urine extracellular vesicles capture kidney transcriptome and hyperglycemia linked mRNA signatures for type 1 diabetic kidney disease
Om Prakash Dwivedi, Karina Barreiro, Annemari Käräjämäki, Erkka Valo, Rashmi B Prasad, Harry Holthöfer, Per-Henrik Groop, Tiinamaija Tuomi, Carol Forsblom, Leif Groop, Maija Puhka
medRxiv 2021.10.11.21264829; doi: https://doi.org/10.1101/2021.10.11.21264829
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Urine extracellular vesicles capture kidney transcriptome and hyperglycemia linked mRNA signatures for type 1 diabetic kidney disease
Om Prakash Dwivedi, Karina Barreiro, Annemari Käräjämäki, Erkka Valo, Rashmi B Prasad, Harry Holthöfer, Per-Henrik Groop, Tiinamaija Tuomi, Carol Forsblom, Leif Groop, Maija Puhka
medRxiv 2021.10.11.21264829; doi: https://doi.org/10.1101/2021.10.11.21264829

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Nephrology
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (552)
  • Anesthesia (135)
  • Cardiovascular Medicine (1752)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (312)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (657)
  • Epidemiology (10792)
  • Forensic Medicine (8)
  • Gastroenterology (586)
  • Genetic and Genomic Medicine (2939)
  • Geriatric Medicine (287)
  • Health Economics (532)
  • Health Informatics (1921)
  • Health Policy (835)
  • Health Systems and Quality Improvement (744)
  • Hematology (291)
  • HIV/AIDS (628)
  • Infectious Diseases (except HIV/AIDS) (12510)
  • Intensive Care and Critical Care Medicine (687)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2791)
  • Nursing (151)
  • Nutrition (432)
  • Obstetrics and Gynecology (557)
  • Occupational and Environmental Health (597)
  • Oncology (1460)
  • Ophthalmology (443)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (363)
  • Primary Care Research (336)
  • Psychiatry and Clinical Psychology (2636)
  • Public and Global Health (5350)
  • Radiology and Imaging (1009)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (726)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)